Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issues

Author： Storosum J.G.   van Zwieten B.J.   Vermeulen H.D.B.   Wohlfarth T.   van den Brink W.  

Publisher： Elsevier

ISSN： 0924-9338

Source： European Psychiatry, Vol.16, Iss.6, 2001-09, pp. : 327-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Augmentation Strategies for Inadequate Antidepressant Response: A Review of Placebo-Controlled Studies

By Coryell W.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 12, Iss. 3, 2000-09 ,pp. : 141-151

Springer Publishing Company

Access to resources Recommend Favorite

A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression

By Olie J.   Gunn K.   Katz E.  

European Psychiatry, Vol. 12, Iss. 1, 1997-01 ,pp. : 34-41

Elsevier

Access to resources Recommend Favorite

Speed of Onset and Efficacy of Sumatriptan Fast-Disintegrating/ Rapid-Release Tablets: Pooled Results of Two Replicate, Randomised, PlaceboControlled Studies

By Dahlöf C.   Cady R.   Poole A.C.   Brandes J.   Few C.   Jones M.  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 277-280

Informa Healthcare

Access to resources Recommend Favorite

Testosterone gel supplementation for men with refractory depression: a randomized placebo-controlled trial

By Pope H.   Cohane G.   Kanayama G.   Siegel A.   Hudson J.  

Journal of Psychosomatic Research, Vol. 55, Iss. 2, 2003-08 ,pp. : 134-134

Elsevier

Access to resources Recommend Favorite

The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective

By Laughren T.P.  

European Psychiatry, Vol. 16, Iss. 7, 2001-11 ,pp. : 418-423

Elsevier

Access to resources Recommend Favorite